1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Humacyte Coronary Tissue Engineered Vessel (CTEV): new trials by email Literature Review of Humacyte Coronary Tissue Engineered Vessel (CTEV) trials Research Report on Humacyte Coronary Tissue Engineered Vessel (CTEV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of Humacyte's Coronary Tissue Engineered Vessel (CTEV) in Patients With Coronary Artery Disease Requiring Coronary Artery Bypass Grafting (CABG) Humacyte Coronary Tissue Engineered Vessel (CTEV) - Coronary Artery Disease | Phase 2 | Not yet recruiting | Humacyte, Inc. | 10 | 2026-09-01 | 2026-07-28 |
Humacyte, Inc. (1)